Muscle acetylcholine receptor ion channels mediate neurotransmission by depolarizing the postsynaptic membrane at the neuromuscular junction. Inherited disorders of neuromuscular transmission, termed congenital myasthenic syndromes, are commonly caused by mutations in genes encoding the five subunits of the acetylcholine receptor that severely reduce endplate acetylcholine receptor numbers and/or cause kinetic abnormalities of acetylcholine receptor function. We tracked the cause of the myasthenic disorder in a female with onset of first symptoms at birth, who displayed mildly progressive bulbar, respiratory and generalized limb weakness with ptosis and ophthalmoplegia. Direct DNA sequencing revealed heteroallelic mutations in exon 8 of the acetylcholine receptor "-subunit gene. Two alleles were identified: one with the missense substitution p."P282R, and the second with a deletion, c.798_800delCTT, which result in the loss of a single amino acid, residue F266, within the M2 transmembrane domain. When these acetylcholine receptor mutations were expressed in HEK 293 cells, the p."P282R mutation caused severely reduced expression on the cell surface, whereas p."ÁF266 gave robust surface expression. Single-channel analysis for p."ÁF266 acetylcholine receptor channels showed the longest burst duration population was not different from wild-type acetylcholine receptor (4.39 AE 0.6 ms versus 4.68 AE 0.7 ms, n = 5 each) but that the amplitude of channel openings was reduced. Channel amplitudes at different holding potentials showed that single-channel conductance was significantly reduced in p."ÁF266 acetylcholine receptor channels (42.7 AE 1.4 pS, n = 8, compared with 70.9 AE 1.6 pS for wild-type, n = 6). Although a phenylalanine residue at this position within M2 is conserved throughout ligand-gated excitatory cys-loop channel subunits, deletion of equivalent residues in the other subunits of muscle acetylcholine receptor did not have equivalent effects. Modelling the impact of p."ÁF266 revealed only a minor alteration to channel structure. In this study we uncover the novel mechanism of reduced acetylcholine receptor channel conductance as an underlying cause of congenital myasthenic syndrome, with the 'low conductance' phenotype that results from the p."ÁF266 deletion mutation revealed by the coinheritance of the low-expressor mutation p."P282R.
Introduction
Congenital myasthenic syndromes are genetic disorders of neuromuscular transmission (Engel et al., 2010) . They are associated with mutations in a series of different proteins that are either directly involved in signal transmission or might be involved in the formation and maintenance of synaptic structure. Prior to the identification of the first congenital myasthenic syndromesassociated mutations it was postulated that mutations of the acetylcholine receptor (AChR) could lead to reduced AChR receptor number at the endplate (Vincent et al., 1981) or altered ion-channel conductance or channel kinetics (Engel et al., 1982 (Engel et al., , 1990 . While mutations that reduce AChR endplate number or alter channel kinetics are common in congenital myasthenic syndromes (Engel et al., 2010) , the identification of mutations that significantly alter channel conductance has been elusive. Evidence that changes to ion-channel conductance might readily occur for the AChR came from work that immediately followed the cloning of the mammalian muscle AChR subunit genes. It was demonstrated that the difference between the adult and foetal forms of the AChR was the respective substitution of the adult "-subunit for the foetal -subunit within the AChR pentamer (Mishina et al., 1986) . Among the differing properties of the foetal and adult AChR were that foetal receptors had a reduced ion-channel conductance but prolonged channel activations (Mishina et al., 1986) . By interchanging residues between the adult and foetal receptors, residues that affected the conductance of the AChR were identified. The studies highlighted that important determinants of conductance were created by residues from the five AChR subunits forming an 'extracellular ring' immediately outside the M2 transmembrane domain that lines the channel pore, and a 'cytoplasmic ring' and an 'intermediate ring' that lie immediately on the cellular side of the M2 region of the pore (Imoto et al., 1988) . The results suggested an electrostatic effect in which negatively charged residues at these positions contribute to increased conductance. Subsequent experimentation and modelling has confirmed this initial study but also point to a more complex picture in which there are additional determinants of conductance and ion selectivity in the extracellular lumen of the channel and that conductance is not solely determined through a simple electrostatic mechanism (Konno et al., 1991; Wang and Imoto, 1992; Kienker et al., 1994; Hansen et al., 2008 . Similarly, the amphipathic membrane-associated stretch of the M3-M4 linker of the related 5HT 3 A receptor ion channel contains three crucial positively charged arginine residues, which influence channel conductance (Kelley et al., 2003) . This region of the molecule forms the portals of the inner vestibule of cys-loop cation channels. The analogous region of the AChR ion channel contains neutral or negatively charged residues and contributes to higher conductance (Hales et al., 2006) . Of these three determinants of single-channel conductance in the AChR ion channel (M2 rings, extracellular domain and membrane-associated), the rings of charged residues close to and within M2 have the greatest influence, and of the M2 rings the intermediate ring at the entrance to the conduction pore exerts the greatest control over conductance (Cymes et al., 2005) .
In congenital myasthenic syndromes the pathogenic mechanism for mutations within the genes that encode the AChR may be via the loss or severe reduction in the number of adult-type receptors at the endplate, or through a change in the kinetics of ion-channel function (Engel et al., 2010) . In the slow channel myasthenic syndrome, there are gain-of-function mutations that are dominant and cause prolonged activations of the AChR (Engel et al., 1996) . Conversely, in fast channel myasthenic syndromes the activations are abnormally brief . Thus, although robust numbers of adult AChR are present at the endplates, these are loss-of-function mutations and the disorder shows recessive inheritance. Some low-expressor mutations may also have 'slow channel-like' or 'fast channel-like' kinetics (Ohno et al., 1997) , but in these cases it is the reduced levels of endplate adult AChR that are the major determinant of phenotype.
Here, we pinpoint a congenital myasthenic syndrome caused by reduced conductance of the AChR ion channel. Surprisingly, the mutation is a deletion within the highly conserved M2 transmembrane domain, which lines the channel pore. Although long considered as a potential pathogenic mechanism this is the first report in which a mutation reducing channel conductance has been found to cause congenital myasthenic syndromes and thus represents a new form of these syndromes.
Materials and methods

Patient DNA analysis
Patient consent was obtained with ethical approval OXREC B: 04.OXB.017 and Oxfordshire REC C 09/H0606/74. DNA was isolated from peripheral blood using the NucleonTM II DNA extraction kit (Nucleon Biosciences). Exons and promoter regions within the AChR subunit genes were screened by bi-direction sequencing of PCR amplicons (Weatherall Institute of Molecular Medicine DNA sequencing facility).
Receptor expression
Naturally occurring and artificial mutations were introduced into complementary DNAs encoding the human muscle AChR subunits using the GeneEditor TM in vitro mutagenesis kit (Promega Corp.)
Complementary DNAs were sequenced following mutagenesis to confirm the presence of the mutated residue and absence of additional variants. Mutant subunit complementary DNAs, in combination with required wild-type AChR -, b-, -and "-subunit complementary DNAs were transfected into HEK 293 cells. Surface AChR expression was determined 2 days post-transfection by overlaying the cells in phosphate-buffered saline containing 10 nM 125 I--bungarotoxin and 1 mg/ml bovine serum albumin for 30 min. Cells were washed four times with phosphate-buffered saline and removed from the plate in 60 mM Tris-HCl (pH 7.4), 100 mM NaCl, 1 mM EDTA, 0.5 mM phenylmethylsulphonyl fluoride and 1.25% Triton X-100. 125 I--bungarotoxin binding was determined by gamma counter. Levels of surface AChR harbouring the "-subunit or "-subunit mutations were measured by immunoprecipitation of the 125 I--bungarotoxin-labelled surface AChR with a human muscle AChR "-subunit-specific polyclonal rabbit antiserum (Newland et al., 1995) (Hamill et al., 1981) at 20-22 C. The cells were bathed in a solution containing (in mM): 150, NaCl; 2.8, KCl; 2, MgCl 2 ; 1, CaCl 2 , 10, HEPES/NaOH; 10, glucose; pH 7.4. The pipette solution was the same as bath solution, except glucose was omitted and acetylcholine added. Single-channel currents were amplified with an Axopatch 200B amplifier (Molecular Devices), and sampled to hard disk at 100 kHz, initially filtered at 5 kHz ( À3 dB, Bessel filter); resolution was set at 50 ms. Burst duration recordings were made with the pipette potential set at + 80 mV. Channel transitions were detected by 50% amplitude threshold crossings (pClamp9). Bursts were defined as groups of openings separated by closed intervals longer than a critical duration (t crit ); t crit was determined for each patch using Equation (1).
where amp 1 and 1 refer to the longest intraburst or cluster closed population and amp 2 and 2 refer to the interburst or -cluster closed population.
Histograms of burst duration were fitted to the sum of exponentials by maximum log likelihood. Significant differences between groups were determined by unpaired Student's t-test, with P 5 0.05 defined as a significant difference. For single-channel conductance measurements pipette holding potential was adjusted; at least four potentials were tested per patch. Only openings of at least 1 ms were used to determine single-channel amplitude at each potential. Collected amplitudes were fit by Gaussian function to determine mean amplitude of events. Cluster open probability was determined for acetylcholine concentrations ranging from 3 to 500 mM. Clusters were separated by determining t crit using Equation (1) to define intra-and intercluster closed times for each patch. Cluster channel openings were defined and open probability within each cluster was determined using QUB software (SUNY).
Results
Features of the patient with congenital myasthenic syndrome
The 49-year-old female patient reported onset of generalized muscle weakness, ophthalmoparesis and ptosis from early infancy. She underwent thymectomy aged 4 years without clear benefit. Weakness has gradually progressed through life, with bouts of respiratory insufficiency reported. Eye movements are severely restricted. She showed clear fatigable ptosis, fatigable limb and bulbar weakness, though her facial muscles are strong. A muscle biopsy was non-diagnostic, but electromyography showed decrement and jitter suggesting a disorder of neuromuscular transmission. Treatment with pyridostigmine was beneficial, but required a high dose of 180 mg 3-hourly; 3,4-diaminopyridine appeared to have no effect. She has a reported history of asthma. At the age of 45 years she suffered a respiratory arrest with hypoxic brain injury that left her severely disabled. There was no family history of a muscle disorder. Antibodies to the AChR or MuSK were not present.
Mutational analysis
Sequencing of the coding exons and flanking sequences of the AChR -, b-, -and "-subunit genes revealed two heterozygous mutations in exon 8 of the "-subunit gene: first a point mutation c.845C4G that results in the missense substitution p."P282R, which is located in the extracellular link between transmembrane domains M2 and M3, and a second three nucleotide deletion c.798_800delCTT, which results in the deletion of phenylalanine at position 266, p."ÁF266, but otherwise maintains the reading frame and the primary amino acid sequence. Analysis of the sequence trace showed that the two mutations are on separate alleles. The p."ÁF266 lies within the M2 transmembrane domain approximately one-third into the pore from the extracellular side. p."P282R lies in the extracellular link between M2 and M3. Both p."F266 and p."P282 are conserved across species and in the homologous position in each of the five muscle AChR subunits. Neither mutation was detected in DNA from 100 normal controls, but p."P282R has been detected as homozygous and heterozygous, respectively in two additional patients with congenital myasthenic syndrome referred to the National Health Service funded National Diagnostic service for congenital myasthenic syndrome, and homozygous in a French patient (Keiko et al., 2006) .
Surface expression
Since 1993 we have correlated the levels of expression of mutant AChR obtained on the surface of HEK 293 cells with in vivo muscle biopsies and patient phenotype and observed in each case that the properties and levels of AChR expressed on the surface of HEK 293 cells both predicts the levels in vivo and informs patient phenotype (n 4 100). AChR containing the mutant "-subunits p."P282R and p."ÁF266 were expressed from respective complementary DNAs transfected into HEK 293 cells. To confirm that the mutant subunits were included in the surface pentamers, "-subunit-specific antibody was used to precipitate the surface -bungarotoxin-bound complexes. Surface expression of AChR containing p."ÁF266 in transfected HEK 293 cells was robust, at 460% of wild-type, whereas surface expression of the "P282 mutant AChR channels was depressed at 515% of wild-type ( Fig. 1) . Although 2 b 2 AChR can be expressed on the surface of HEK 293 cells and bind -bungarotoxin, as expected these complexes were not precipitated by the anti-"-subunit antibody.
Burst duration
The functional consequences of these mutations was assessed by analysis of burst duration of channels transiently transfected into HEK 293 cells (Fig. 2 ). Recordings were made at low acetylcholine concentration (500 nM) when activations occur in well separated, non-desensitizing, bursts. In wild-type (b") AChR channels burst durations occur in three populations (Table 1 ). The longest of these populations is the most important physiologically, since these represent activations when both binding sites are occupied and are likely to dominate when acetylcholine is released into the neuromuscular synapse at high concentration. The longest burst duration population (3) for wild-type channels was 4.68 AE 0.74 ms. For the p."ÁF266 deletion mutation the longest burst duration population (3) was unchanged (4.39 AE 0.60 ms), while for the p."P282R missense mutation burst durations were best fit by only two exponential functions, the longest burst duration mean being only 1.43 AE 0.20 ms. To ascertain that these channel events were not from channels formed without an "-subunit (i.e. 2 b 2 AChR) recordings were made from cells transfected with only b AChR complementary DNAs. These channel events had mean longest burst duration of 9.32 AE 0.27 ms (n = 3). To determine the efficacy of acetylcholine in activating the mutant channels we measured cluster open probability over a range of desensitizing acetylcholine concentrations (Fig. 3) . This showed acetylcholine as effective at activating the mutant channels as it is for wild-type AChR with no change in EC 50 (half maximal effective concentration).
Conductance
At the pipette holding potential of + 80 mV the single-channel amplitude of p."ÁF266 AChR was reduced compared with wild-type channels. This was further investigated by holding the patch at various potentials to investigate the single-channel conductance of these channels (Fig. 4) . Single-channel openings were detected and fit by a single Gaussian population at various holding potentials; data for each patch were subjected to a linear fit to give the slope conductance. At each holding potential p."ÁF266 channel amplitude was reduced. Compared to wild-type channels p."ÁF266 channels conductance was reduced by $40% from 70.9 AE 1.6 pS to 42.7 AE 1.4 pS.
Co-expression of ab"ÁF266 and ab"P282R in HEK 293 cells
Haploinsufficiency does not play a role in congenital myasthenic syndromes involving mutations in the AChR, where carriers who are heterozygous for a low-expressor congenital myasthenic syndromes mutation in combination with the wild-type allele show no defect in neuromuscular transmission and have normal endplates. However, it is possible that expression of b"P282R might compete with b"ÁF266 at the endplates and severely reduce the level of AChR, thus leading to AChR deficiency. To address this possibility we co-expressed b"ÁF266 and b"P282R in HEK 293 cells and measured the level of cell surface 125 I--bungarotoxin binding to AChR harbouring the "-subunits.
A similar reduction compared with wild-type was seen when b"ÁF266 and b"P282R were expressed together as is seen when b"ÁF266 is expressed on its own (Fig. 5A) . To investigate further the expression of the two mutants, single-channel recordings were made from the HEK 293 cells expressing the b"ÁF266 and b"P282R combination. Channel expression is shown from one of five patches ( Fig. 5B) with similar results seen in patches from another four cells. The recordings show that the great majority of channels are of the lower amplitude and open time characteristic of b"ÁF266 receptors, whereas there is a very small population of higher amplitude but brief opening channels characteristic of b"P282R receptors. The results show that when b"ÁF266 and b"P282R are expressed together, surface expression of "-subunit-containing AChR remains relatively robust and that the overwhelming majority of the AChR harbour the p."ÁF266 mutation. Thus, it is the characteristics of this mutation that are likely to govern the phenotype of the patient.
Equivalent deletions
The deleted phenylalanine at position 266 in the "-subunit is conserved at the equivalent position within the transmembrane domain in all subunits of the muscle AChR (Fig. 6C ). This residue lies in the top third of the M2 transmembrane domain close to the extracellular ring, which has been shown to influence the singlechannel conductance of AChR (Imoto et al., 1988) . To ascertain if the equivalent residues within the M2 domain from the other AChR subunits play a role in determining conductance in a similar manner to the "-subunit, the equivalent phenylalanine in each of the four other subunits was deleted and these mutant constructs expressed in HEK 293 cells. Surface expression experiments revealed that the -subunit deletion did not form surface channels; however, the three other deletion mutations did give surface expression (ÁF256, 2.6 AE 0.8% of wild-type; bÁF268, 34.2 AE 7.1%; ÁF270, 12.6 AE 1.7%; and ÁF265, 79.4 AE 16.5% of wild-type -subunit-containing AChR). The levels of surface expression of the AChR incorporating the mutant -subunit were determined using a -subunit-specific antibody.
The functional consequence of the b-, -and -subunit deletions was assessed in a similar manner to the p."ÁF266 deletion mutation. Channel activity from b(ÁF268)" AChR was a mixture of conventional openings and more frequently 'flickery' openings, which did not have a sustained full amplitude (Fig. 7A ). This type of activity was seen in many different patches, although the proportion of normal to abnormal openings did vary. Due to the mixture of channel activity further analysis could not be performed. Channel activity from b(ÁF270)" AChR appeared similar to wild-type channels (Fig. 7B) , with the mean of the longest burst duration population of 3.80 AE 0.30 ms (n = 5) and a single-channel conductance of 67.9 AE 4.5 pS (n = 7). Activity of b(ÁF265) AChR channels, despite robust surface expression, were very short-lived and rare (Fig. 7C) ; when sufficient activity was observed the longest burst duration was only 0.51 AE 0.02 ms (n = 3), compared with 7.77 AE 0.32 ms (n = 3) for wild-type -containing channels.
Structural implications of "ÁF266 deletion
Jalview (Clamp et al., 2004) and MAFFT (Katoh et al., 2002) were used to align the sequences for the adult (containing the "-subunit) human AChR with GLIC (PDB identifier: 3EHZ) and Torpedo AChR (PDB: 2BG9). Sequences for the M2 helices, and in the case of the "-subunit for the M3 helix, were removed. The homology modelling software Modeller (Š ali and Blundell, 1993) was used to make 100 attempts at generating human AChR models; the model with the optimal objective-function value was chosen for subsequent investigation. Models for the "-subunit deletion mutant ÁF266 and for the foetal variant (containing the -subunit) were made using the same procedure. In making the homology models for the human AChR, the M2-loop-M3 region of the "-subunit required special attention. A reasonable model of this region only resulted by removing the template Torpedo structure here and relying solely on the GLIC structure. The modelling failed to detect significant changes in structure that might underlie the observed alteration in conductance.
Discussion
We traced the clinical phenotype of a congenital myasthenic syndrome to the deletion of a phenylalanine residue at position F266 in the M2 transmembrane domain of the nicotinic AChR "-subunit. The functional consequences of the p."ÁF266 mutation are unmasked by the low-expressor mutation p."P282R on the second allele of the "-subunit. Although residue "F266 is located within the highly conserved channel pore-forming domain, "-subunits with "F266 deleted are incorporated into the AChR pentamer and show robust cell surface expression in HEK 293 cells. Analysis of single-channel recordings from the mutant AChR show p."ÁF266 does not significantly alter the burst duration kinetics but rather reduces the single-channel conductance. The analysis reveals a new mechanism through which human mutations of the AChR ion channel can impair neuromuscular transmission and defines a new subtype of hereditary myasthenia, a low channel-conductance congenital myasthenic syndrome. p."ÁF266 causes a loss-of-function and therefore, in a similar fashion to fast channel syndrome mutations, an additional mutation on the second allele is required to unmask the phenotype. Here, the second mutation p."P282R results in severely reduced surface expression when expressed in HEK293 cells and is comparable to levels found with other low-expressor/null "-subunit mutations (Ealing et al. 2002; Beeson, unpublished data) . We were able to demonstrate this by using an "-subunit-specific antibody to pull down the 125 I--bungarotoxin-labelled cell surface AChR and thus differentiate between AChR harbouring p."P282R subunits and AChR consisting of 2 b 2 subunits. This is important, since 2 b 2 AChR pentamers can give levels of cell surface 125 I--bungarotoxin-binding that are up to 40% of wild-type 2 b" AChR (Ohno et al., 1997; Ealing et al., 2002) . Our results suggest that the primary pathogenic effect of p."P282R is through reduced expression of the AChR, and that the secondary fast channel kinetics of this mutation, that have been previously reported (Keiko et al., 2006) and are shown here, compound this effect. When b"P282R and b"ÁF266 were co-expressed b"ÁF266 remains well expressed as demonstrated by cell surface expression. When the two mutant forms were co-expressed the functional channels were characteristic of b"ÁF266 with a very small number of detectable b"P282R channels. Thus it is likely that b"ÁF266 would predominate at the endplate and b"P282R would only play a very minor role in determining signal transduction. The deletion of "F266 reduces the single-channel conductance of the AChR (70.9 AE 1.6 pS to 42.7 AE 1.4 pS), which in common with the modest reduction in expression will reduce the current flow at the endplate and should markedly compromise the safety margin of neuromuscular transmission. The observation that the open probability dose response curve was not shifted by the deletion mutation is consistent with the observation that the burst duration of the longest burst population was unchanged compared with wild-type. Slow-channel type perturbations that enhance channel gating kinetics would be expected to left-shift the dose response curve and also prolong burst durations. Similarly fast-channel type perturbations that reduce the efficiency of channel gating would be expected to cause a right-shift of the dose response curve and shorten burst durations (Shen et al., 2005) . These combined observations indicate that the pathophysiological effect of this deletion mutation is unlikely to be via a shift in the gating kinetics of the AChR ion channel. At the highest concentrations of ACh, open probability was reduced compared to wild-type AChR. This is perhaps due to alterations in channel block by acetylcholine or an increased propensity for fast desensitization. However, these effects are unlikely to affect the physiological function of the ion channel at the neuromuscular synapse. Although a detailed kinetic analysis was not performed, acetylcholine was as effective at activating the mutant b"ÁF266 channels as wild-type, although there was a reduction in the absolute maximal activation at high concentrations. This may have been due to an increased propensity to desensitization within clusters (Jadey et al., 2011) .
The molecular mechanism by which the deletion of F266 in the "-subunit alters channel conductance is not clear. The phenylalanine at position 266 (position 14 in the M2 domain) is conserved both in all the muscle AChR subunits, and in all cys-loop ligand-gated excitatory receptor ion channels (which includes Amplitude of channel events 41 ms in duration were averaged for each potential (40 mV, 80 mV, 100 mV and 120 mV) for each patch, error bars are less than size of symbol. For each patch a linear fit of the data was applied, giving the single-channel conductance for each patch. Mean AE SEM conductance indicated are from six and eight patches, respectively. neuronal nicotinic AChR and 5HT 3 receptors) suggesting that it must play an important role in channel function. It is therefore somewhat surprising that deletion of this residue from within the crucial M2 functional domain of the "-subunit does not have a major effect either on levels of surface expression or channel gating.
Adjacent to the p." ÁF266 deletion, at position 13 of M2, is a valine residue (invariant in the cationic cys-loop channel family), which is hypothesized to form part of the hydrophobic gate restricting movement of extracellular cations. The hydrophobic pore is thought to be narrow at this point and increased by only a small amount (0.5-1.0 Å ), though was sufficient to allow passage of cations when a large transmembrane voltage was applied (Wang et al., 2008) . Disruption to the small movement within the pore by deletion of the adjacent F266 residue may hamper translocation of cations manifested by a reduction in overall channel conductance.
Similar small changes in pore diameter to allow rapid ion translocation were demonstrated by Cymes and Grosman (2008) .
Additionally, "F266 resides six positions below the extracellular ring of charged residues at the upper membrane interface thought to be crucial in conferring a difference in conductance between foetal and adult AChR (Imoto et al., 1988; Bouzat and Barrantes, 1997) . Modelling of the structural changes that occur at the top of M2 and the loop to the top of the M3 region does not suggest a large change in the structure or alter the electrostatic interaction with positive ions as they traverse the pore. However, the precise structural changes that occur when the F266 residue is removed are not known; the modelling we performed assumed that adjacent residues moved from both directions. While electrostatic calculations (not shown) could not explain conductance changes in the deletion mutant, they showed qualitative differences consistent with the difference in conductance between the -and "-containing channels. The deleted phenylalanine residue in the "-subunit did not point into the pore in the model. Since this residue was not charged, the changes in electrostatics could at most be subtle. It should be noted that the structures (Torpedo and GLIC) on which our modelling was based are thought to be of the channel in the closed state (Unwin, 2005; Beckstein and Sansom, 2006; Gonzalez-Gutierrez and Grosman, 2010) . The consequence of the deletion on the open conformation may well be more significant but can't be determined by our modelling.
One possible mechanism for the influence of the "F266 deletion on channel conductance comes from a comparison of the -and "-subunit composition of the extracellular ring. For the -subunit there is positive lysine while for "-subunit there is a neutral glutamine. However, if the deletion of F266 causes the helix to shift downwards the glutamine is replaced by lysine, analogous to the -subunit. This shift causes a + 1 change in net charge within the ring, similar to interchanging the -and "-subunits and might explain why the "ÁF266 channel conductance is converted to $45 pS, similar to the conductance of the -containing foetal AChR channel.
To test this hypothesis we engineered equivalent phenylalanine deletions in each of the muscle AChR subunits and assessed the effect on channel function. A change in the composition of the extracellular ring, and consequently its net charge, might have predictable consequences for channel activity. For the -subunit the predicted shift would result in a negative glutamic acid being replaced by neutral leucine at two positions in the ring, with a net + 2 change in the ring charge. However, this channel did not express on the cell surface and so we cannot determine what influence this might have had on channel function and/or conductance. In the b-subunit a negatively charged aspartic acid would be replaced by a positive lysine in the extracellular ring, resulting in a + 2 change in net charge. This resulted in a complex change in channel activity, many channel activations were flickery and did not maintain a full amplitude opening for the duration of the opening, although there were some full amplitude openings. This mixture of channel activities prevented any further analysis of burst duration or conductance. However, it is possible to determine that a simple change in channel conductance did not result from this deletion mutation in the b-subunit. In the -subunit, deletion of F270 results in a conservative change in the extracellular ring, lysine to an arginine, with no change in the net charge within the ring. The activity of channels containing this subunit was relatively unaffected; burst duration and conductance was similar to wild-type. However in the -subunit, where deletion of F265 does not result in a change of residue in the extracellular ring, the function of the channel is severely disrupted. Only very brief channel openings are detected. In the case of the b-subunit, where flickery channels were observed, this could be the result of forcing the polar aspartic acid residue deeper into the membrane environment and destabilizing the pore structure and interfering with channel gating. Thus, equivalent mutations to the -, b-and -subunits disrupted channel function to the extent that alterations to conduction could not be ascertained. The data from the -subunit where AChR function was maintained is consistent with the hypothesis that the shift in register of the M2 helix so that the positively charged lysine replaces the glutamine at the extracellular ring is the key factor governing the observed change in AChR conductance.
The clinical features of the patient share some characteristics with the fast channel syndrome. Symptoms are present from birth; there is generalized weakness with marked ptosis, ophthalmoparesis and some bulbar difficulties. As is common in the fast channel syndrome, bouts of respiratory insufficiency that can be life-threatening were noted in the patient with low conductance congenital myasthenic syndrome. Anti-cholinesterase medication shows some beneficial effects. In both syndromes reduced current through the adult endplate receptors is likely to restrict activation of the postsynaptic voltage-gated sodium channels. Some modest effects on channel conductance have been reported for pathogenic mutations affecting gating in cys-loop ion-channel receptors, but here we provide the first example of reduced ion-channel conductance as a primary pathogenic molecular mechanism of the muscle AChR. There is the potential that mutations altering channel conductance in related cys-loop ion channels may similarly impair synaptic transmission in the CNS.
